Tirzepatide is indicated with diet and exercise to lower blood sugar levels in people with type 2 diabetes.

Tirzepatide is a drug that shows promise in combating one of the most common chronic diseases in the world: type 2 diabetes. The new drug Tirzepatide is a dual antagonist of the glucose-dependent tropical insulin polypeptide (GIP) and the GLP-1 receptor. , which means that it directly activates the GIP and GLP-1 receptors in the body. These receptors increase insulin production and therefore help reduce excess blood sugar. In addition, it delays stomach emptying, making it a potentially useful drug against obesity, which is often correlated with type 2 diabetes. About 10% of the world’s population is estimated to have diabetes. This disease develops over time and is most often diagnosed in elderly patients. This can be due to many different external factors in the form of repeated unhealthy behaviors.

Tirzepatide can cause side effects and some could be dangerous. These would be the following: Nausea, vomiting, diarrhea, decreased appetite, constipation, and stomach pain that does not go away and may spread to the back.

It is very important to see your doctor if you have any of these symptoms and you should tell your doctor and pharmacist if you are allergic to tirzepatide.

https://www.conexiones365.com/nota/expo-med/innovacion/8-avances-medicos-2023

https://d-medical.com/2022/06/tirzepatida-el-medicamento-para-la-diabetes-que-logra-una-perdida-de-peso-equivalente-a-la-cirugia/

https://medlineplus.gov/spanish/druginfo/meds/a622044-es.html#if-i-forget

https://www.redgdps.org/la-fda-aprueba-tirzepatida-mounjaro-para-el-tratamiento-de-la-diabetes-tipo-2-en-eeuu